Chilblain lupus induced by TNF-α antagonists: A case report and literature review

Clinical Rheumatology

Volumn 31, Issue 3, 2012, Pages 563-568

  Sifuentes Giraldo, Walter A ^a   Ahijón Lana, María ^a   García Villanueva, María Jesús ^a   González García, Carmen ^a   Vázquez Diaz, Mónica ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Ankylosing spondylitis; Chilblain lupus; Drug induced lupus; Infliximab; TNF antagonists

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DNA ANTIBODY; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; NIFEDIPINE; PREDNISONE;

AGED; ANKYLOSIS; ANTIBODY TITER; ANTIGEN DETECTION; ARTHRITIS; ARTICLE; AUTUMN; BACKACHE; CASE REPORT; CD3+ T LYMPHOCYTE; CHILBLAIN LUPUS; COLD EXPOSURE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DOPPLER ECHOGRAPHY; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; INFLAMMATORY INFILTRATE; MALE; METATARSOPHALANGEAL JOINT; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS; UVEITIS; WINTER;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILBLAINS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859748013     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1924-x     Document Type: Article

References (25)

1. Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ (2009) Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 61(3):486-504. doi:10.1016/j.jaad.2008.10.060
2. Vedove CD, Del Giglio M, Schena D, Girolomoni G (2009) Drug-induced lupus erythematosus. Arch Dermatol Res 301(1):99-105. doi:10.1007/s00403-008-0895-5
3. Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, Heubner G, Lee-Kirsch MA, Gahr M (2008) Chilblain lupus erythematosus-a review of literature. Clin Rheumatol 27(8):949-954. doi:10.1007/s10067-008-0942-9
4. Bielsa IHC (2009) Manifestaciones cutáneas. In: Kamashta MVM (ed) Lupus Eritematoso Sistémico, Thirdth edn. Caduceo Multimedia S.L, Barcelona, pp 115-126
5. Ramos-Casals M, Roberto Perez A, Diaz-Lagares C, Cuadrado MJ, Khamashta MA (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9 (3):188-193. doi:10.1016/j.autrev.2009.10.003
6. Gonnet-Gracia C, Barnetche T, Richez C, Blanco P, Dehais J, Schaeverbeke T (2008) Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 26(3):401-407 (Pubitemid 352003207)
7. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F (2005) The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 14(12):931-937 (Pubitemid 43088266)
8. Williams VL, Cohen PR (2011) TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 50(5):619-625. doi:10.1111/j.1365-4632.2011.04871.x
9. Pink AE, Fonia A, Allen MH, Smith CH, Barker JN (2010) Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 162(4):780-785. doi:10.1111/j.1365-2133.2009.09563.x
10. Viana VS, de Carvalho JF, de Moraes JC, Saad CG, Ribeiro AC, Goncalves C, Bueno C, Vendramini MB, Bonfa E (2010) Autoantibodies in patients with psoriatic arthritis on anti-TNFalpha therapy. Rev Bras Reumatol 50(3):225-234
11. Beigel F, Schnitzler F, Paul Laubender R, Pfennig S, Weidinger M, Goke B, Seiderer J, Ochsenkuhn T, Brand S (2011) Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease. Inflamm Bowel Dis 17(1):91-98. doi:10.1002/ibd.21362
12. Costa MF, Said NR, Zimmermann B (2008) Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 37(6):381-387. doi:10.1016/j.semarthrit.2007.08.003 (Pubitemid 351734520)
13. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 86(4):242-251. doi:10.1097/MD. 0b013e3181441a68 (Pubitemid 47067483)
14. Hutchinson J (1888) Harveian lectures on lupus. Br Med J 1(1411):58-63
15. Obermoser G, Sontheimer RD, Zelger B (2010) Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 19(9):1050-1070. doi:10.1177/0961203310370048
16. María G-H, del Rosario GPR, Ricardo SA (2002) Perniosis lúpica. Piel 17(6):254-258
17. Boada A, Bielsa I, Fernandez-Figueras MT, Ferrandiz C (2010) Perniosis: clinical and histopathological analysis. Am J Dermatopathol 32(1):19-23. doi:10.1097/DAD.0b013e3181af1d24
18. Viguier M, Pinquier L, Cavelier-Balloy B, de la Salmoniere P, Cordoliani F, Flageul B, Morel P, Dubertret L, Bachelez H (2001) Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine 80(3):180-188
19. Richez C, Dumoulin C, Schaeverbeke T (2005) Infliximab induced chilblain lupus in a patient with rheumatoid arthritis. J Rheumatol 32(4):760-761 (Pubitemid 40524717)
20. Saint Marcoux B, De Bandt M (2006) Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710-713. doi:10.1016/j.jbspin.2006.02.010 (Pubitemid 44918417)
21. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X (2005) Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 7(3):R545-R551. doi:10.1186/ar1715
22. Muller S, Dieker J, Tincani A, Meroni PL (2008) Pathogenic antinucleosome antibodies. Lupus 17(5):431-436. doi:10.1177/0961203308090030
23. Duzgun N, Sahin M, Genc Y, Tutkak H (2007) Antinucleosome antibodies and systemic lupus erythematosus. Ann N Y Acad Sci 1109:421-428. doi:10.1196/annals.1398.048 (Pubitemid 47511385)
24. De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F (2003) Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum 48(4):1015-1023. doi:10.1002/art.10876 (Pubitemid 36418243)
25. Lutz V, Cribier B, Lipsker D (2010) Chilblains and antiphospholipid antibodies: report of four cases and review of the literature. Br J Dermatol 163(3):645-646. doi:10.1111/j.1365-2133.2010.09829.x